Cargando...

P08.58 Upfront chemotherapy in grade III gliomas: an institutional retrospective series

INTRODUCTION: Grade III gliomas are diseases with different molecular features, therapeutic responses and prognosis. In the last decades, markers like 1p/19q codeletion, methylation of MGMT promoter, IDH1, ATRX and TERT mutations have been detected: up to date they are known to be prognostic factors...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Bruno, F., Magistrello, M., Franchino, F., Pellerino, A., Nicolotto, E., Garbossa, D., Bertero, L., Cassoni, P., Rudà, R., Soffietti, R.
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2016
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5782686/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.191
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!